CARY, N.C. (AP) — CARY, N.C. (AP) — Heron Therapeutics Inc. (HRTX) on Friday reported a loss of $2.4 million in its second quarter.
The Cary, North Carolina-based company said it had a loss of 2 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 1 cent per share.
The pharmaceutical company posted revenue of $37.2 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $37.9 million.
Heron Therapeutics expects full-year revenue in the range of $153 million to $163 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HRTX at https://www.zacks.com/ap/HRTX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
